Contact information
Peter Scanlon
MD FRCP FRCOphth FHEA DCH DRCOG DO
Associate Professor
- Tutor and Senior Research Fellow, Harris Manchester College
Prof. Peter Scanlon has been Clinical Director for the English NHS Diabetic Eye Screening Programme since 2003, and he has, with the support and co-operation of colleagues, moved screening from limited ad hoc delivery of services to systematic quality assured processes for screening, assessment and treatment across all of England to 2.3 million people with diabetes. Dr Scanlon also holds an appointment as a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and as Visiting Professor at the University of Gloucestershire. Dr Scanlon is Lead Author of the textbook ‘Practical Manual of Diabetic Retinopathy Management’ and has written the Diabetic Retinopathy Chapter for the Textbook of Diabetes, 4th Edition (both Wiley Blackwell).
His research interests lie in the Screening, Epidemiology, Assessment and Treatment of Diabetic Retinopathy and he has published extensively in these areas.
Recent publications
-
Improving the screening of risk factors in diabetic retinopathy.
Journal article
Scanlon PH., (2022), Expert Rev Endocrinol Metab, 17, 235 - 243
-
Why Is Continued Vision Loss Still a Problem in Some Patients With Diabetic Retinopathy, Despite Treatment?
Journal article
Bressler SB. et al, (2022), JAMA Ophthalmol, 140, 308 - 309
-
Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre.
Journal article
Scanlon PH. et al, (2022), Eye (Lond), 36, 646 - 648
-
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years.
Journal article
Talks SJ. et al, (2022), Eye (Lond), 36, 72 - 77
-
Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy
Journal article
Prior L. et al, (2022), Eye (Basingstoke)